TNF and autoimmune disease: Several therapeutic approaches targeting T cell activation (i.e., Janus kinase inhibitors) and proinflammatory cytokines (i.e., antibodies against IL17, IFNγ, and TNFα) have been developed for the treatment of autoimmune disorders.